Trial intelligence / Profile preview

Bilevel NIV vs Salbutamol in Asthma after Bronchoprovocation

NCT03430505Completed

Sponsor
University of Nove de Julho
Start
Jun 2017
Primary completion
Jul 2018
Countries
1
01

Overview

Randomised, open-label trial in asthma (2 arms), sponsored by University of Nove de Julho. Primary endpoints: Forced Expiratory Volume in 1 Second at 1 hour, Expiratory time at 1 hour and 1 more. Started Jun 2017; status: completed.

02

Conditions

asthma

Beyond the preview

Go deeper on NCT03430505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03430505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call